VIR - Vir Biotechnology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.49B
Enterprise Value 1.37B
Trailing P/E 5.92
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.82
Price/Book (mrq)1.77
Enterprise Value/Revenue 3.44
Enterprise Value/EBITDA -4.37

Trading Information

Stock Price History

Beta (5Y Monthly) 0.26
52-Week Change 34.16%
S&P500 52-Week Change 34.08%
52 Week High 331.78
52 Week Low 318.05
50-Day Moving Average 324.83
200-Day Moving Average 324.54

Share Statistics

Avg Vol (3 month) 3908.97k
Avg Vol (10 day) 3859.62k
Shares Outstanding 5133.98M
Implied Shares Outstanding 6N/A
Float 886.46M
% Held by Insiders 114.24%
% Held by Institutions 173.82%
Shares Short (May 14, 2023) 45.05M
Short Ratio (May 14, 2023) 46.24
Short % of Float (May 14, 2023) 46.37%
Short % of Shares Outstanding (May 14, 2023) 43.77%
Shares Short (prior month Apr 13, 2023) 44.79M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin -32.19%
Operating Margin (ttm)-64.29%

Management Effectiveness

Return on Assets (ttm)-6.46%
Return on Equity (ttm)-7.24%

Income Statement

Revenue (ttm)446.3M
Revenue Per Share (ttm)3.36
Quarterly Revenue Growth (yoy)-94.90%
Gross Profit (ttm)1.03B
EBITDA -276.06M
Net Income Avi to Common (ttm)-143.68M
Diluted EPS (ttm)-1.16
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.25B
Total Cash Per Share (mrq)16.8
Total Debt (mrq)128.73M
Total Debt/Equity (mrq)6.53
Current Ratio (mrq)4.86
Book Value Per Share (mrq)14.72

Cash Flow Statement

Operating Cash Flow (ttm)987.38M
Levered Free Cash Flow (ttm)853.38M